Clinical trials - Press Releases

Date	Title	Company
23-Dec-2019	Nanoform files for GMP certification	Nanoform
23-Dec-2019	Abeona Therapeutics Receives European Medicines Agency PRIME Designation for ABO-102 Gene Therapy in MPS IIIA	Abeona Therapeutics Inc
23-Dec-2019	AstraZeneca’s triple-combination therapy approved in China for patients with COPD	AstraZeneca
23-Dec-2019	ViiV Healthcare receives complete response letter from US FDA for use of investigational cabotegravir and rilpivirine long-acting regimen in the treatment of HIV	ViiV Healthcare
23-Dec-2019	Enhertu (trastuzumab deruxtecan) approved in the US for HER2-positive unresectable or metastatic breast cancer following two or more prior anti-HER2 based regimens	AstraZeneca
23-Dec-2019	U.S. FDA APPROVES EISAI’S DAYVIGO™ (LEMBOREXANT) FOR TREATMENT OF INSOMNIA IN ADULT PATIENTS	Eisai Co., Ltd
23-Dec-2019	Akari Therapeutics Announces Initiation of Pivotal Phase III Trial of Nomacopan in Pediatric Hematopoietic Stem Cell Transplant-Related Thrombotic Microangiopathy (HSCT-TMA) Following the Opening of its IND	Akari Therapeutics, Plc
20-Dec-2019	Bavarian Nordic Announces the Sale of Priority Review Voucher	Bavarian Nordic
20-Dec-2019	Sartorius and the German Research Center for Artificial Intelligence Launch Joint Research Laboratory	Sartorius
20-Dec-2019	Aglaia Oncology Funds and Sinzer - Grant Thornton Launch Dedicated Life Sciences Impact Measuring and Reporting Suite	Aglaia Oncology Funds
20-Dec-2019	RINVOQ® ▼(upadacitinib) Granted EU Marketing Authorisation for the Treatment of Eligible Adults with Moderate to Severe Active Rheumatoid Arthritis	AbbVie
19-Dec-2019	Large Real-World Data Confirm Safety and Effectiveness of LIXIANA®▼ (edoxaban) in Routine Clinical Practice for Elderly AF Patients with Comorbidities	Daiichi Sankyo Europe GmbH
19-Dec-2019	Sanofi wins prestigious drug discovery award for innovative rare blood clotting disorder treatment	Sanofi UK
19-Dec-2019	BC Platforms Closes $15 million Series C Financing and Signs Partnership with IQVIA to Extend Data Analytics in Genomics	BC Platforms
19-Dec-2019	Nordic Nanovector awarded NOK 12 million in funding from the Norwegian Research Council to advance Alpha37, a targeted alpha therapy for B-cell cancers	Nordic Nanovector ASA
19-Dec-2019	Cambridge Semantics Expands to Australia and New Zealand	Cambridge Semantics
19-Dec-2019	World first treatment with ‘acoustic cluster therapy’ to improve chemotherapy delivery	The Institute of Cancer Research, London,
19-Dec-2019	Nobel Prize winning research prompts new cancer treatments	GlobalData
19-Dec-2019	David Hale appointed CEO of Guerbet as from January 1, 2020 to accelerate deployment of the Group's strategy	Guerbet
19-Dec-2019	Median Technologies announces the signing of a € 35 million finance contract with the European Investment Bank (EIB)	Median Technologies